<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8852698" created="06/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8852698</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="selenium-mediated_inhibition" sem="Other"><term id="T2" lex="selenium" sem="Organic_compound_other">Selenium</term>-mediated inhibition</term> of <term id="T3" lex="transcription_factor_NF-kappa_B" sem="Protein_complex">transcription factor NF-kappa B</term> and <term id="T4" lex="HIV-1_LTR_promoter_activity" sem="Other"><term id="T5" lex="HIV-1_LTR_promoter" sem="DNA_domain_or_region">HIV-1 LTR promoter</term> activity</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<cause idref="T2"/>
<clue>Selenium-<linkCause>mediated</linkCause> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> transcription factor NF-kappa B and HIV-1 LTR promoter activity.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="T5"/>
<cause idref="T2"/>
<clue>Selenium-<linkCause>mediated</linkCause> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> transcription factor NF-kappa B and HIV-1 LTR promoter activity.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T6" lex="eukaryotic_transcription_factor_NF-kappa_B" sem="Protein_complex">eukaryotic transcription factor <term id="T7" lex="transcription_factor_NF-kappa_B" sem="Protein_complex">NF-kappa B</term></term> is involved in the inducible expression of various <term id="T8" lex="inflammatory_gene" sem="DNA_family_or_group">inflammatory genes</term> as well as in <term id="T9" lex="HIV-1_replication" sem="Other"><term id="T10" lex="HIV-1" sem="Virus">HIV-1</term> replication</term>.</sentence>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T8"/>
<clue>The eukaryotic transcription factor NF-kappa B is involved in the inducible <clueType>expression</clueType> <linkTheme>of</linkTheme> various inflammatory genes as well as in HIV-1 replication.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T7"/>
<clue>The eukaryotic transcription factor NF-kappa B is <clueType>involved</clueType> <linkTheme>in</linkTheme> the inducible expression of various inflammatory genes as well as in HIV-1 replication.</clue>
<comment>NER T7 mod</comment></event>
<event KT="Other" id="E5">
<type class="Viral_life_cycle"/>
<theme idref="T10"/>
<clue>The eukaryotic transcription factor NF-kappa B is involved in the inducible expression of various inflammatory genes as well as in HIV-1 <clueType>replication</clueType>.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T7"/>
<clue>The eukaryotic transcription factor NF-kappa B is <clueType>involved</clueType> in the inducible expression of various inflammatory genes as well as <linkTheme>in</linkTheme> HIV-1 replication.</clue>
</event>
<sentence id="S3">Activation of <term id="T11" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> is induced by <term id="T12" lex="prooxidant" sem="Organic_compound_other">prooxidants</term> and several stimuli eliciting <term id="T13" lex="oxidative_stress" sem="Other">oxidative stress</term>, such as <term id="T14" lex="cytokine" sem="Protein_family_or_group">cytokines</term>, <term id="T15" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term>, <term id="T16" lex="UV_irradiation" sem="Other">UV irradiation</term> and <term id="A1" sem="Other">other mediators</term>.</sentence>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> NF-kappa B is induced by prooxidants and several stimuli eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T12"/>
<clue>Activation of NF-kappa B is <clueType>induced</clueType> <linkCause>by</linkCause> prooxidants and several stimuli eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Fact" id="E34">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T14"/>
<clue>Activation of NF-kappa B is <clueType>induced</clueType> <linkCause>by</linkCause> prooxidants and <corefCause>several stimuli</corefCause> eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Fact" id="E35">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T15"/>
<clue>Activation of NF-kappa B is <clueType>induced</clueType> <linkCause>by</linkCause> prooxidants and <corefCause>several stimuli</corefCause> eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Fact" id="E36">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T16"/>
<clue>Activation of NF-kappa B is <clueType>induced</clueType> <linkCause>by</linkCause> prooxidants and <corefCause>several stimuli</corefCause> eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Fact" id="E37">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="A1"/>
<clue>Activation of NF-kappa B is <clueType>induced</clueType> <linkCause>by</linkCause> prooxidants and <corefCause>several stimuli</corefCause> eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T14"/>
<clue>Activation of NF-kappa B is induced by prooxidants and <corefCause>several stimuli</corefCause> <clueType>eliciting</clueType> oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T15"/>
<clue>Activation of NF-kappa B is induced by prooxidants and <corefCause>several stimuli</corefCause> <clueType>eliciting</clueType> oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T16"/>
<clue>Activation of NF-kappa B is induced by prooxidants and <corefCause>several stimuli</corefCause> <clueType>eliciting</clueType> oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="A1"/>
<clue>Activation of NF-kappa B is induced by prooxidants and <corefCause>several stimuli</corefCause> <clueType>eliciting</clueType> oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators.</clue>
</event>
<sentence id="S4">Various <term id="T17" lex="antioxidant" sem="Organic_compound_other">antioxidants</term> inhibit <term id="T18" lex="NF-kappa_B_activation" sem="Other"><term id="T19" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> in response to these stimuli.</sentence>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<cause idref="T14"/>
<clue>Various antioxidants inhibit NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> <corefCause>these stimuli</corefCause>.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<cause idref="T15"/>
<clue>Various antioxidants inhibit NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> <corefCause>these stimuli</corefCause>.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<cause idref="T16"/>
<clue>Various antioxidants inhibit NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> <corefCause>these stimuli</corefCause>.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<cause idref="A1"/>
<clue>Various antioxidants inhibit NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> <corefCause>these stimuli</corefCause>.</clue>
</event>
<event KT="Fact" id="E17">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T17"/>
<clue>Various antioxidants <clueType>inhibit</clueType> NF-kappa B activation in response to these stimuli.</clue>
</event>
<event KT="Fact" id="E18">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T17"/>
<clue>Various antioxidants <clueType>inhibit</clueType> NF-kappa B activation in response to these stimuli.</clue>
</event>
<event KT="Fact" id="E19">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T17"/>
<clue>Various antioxidants <clueType>inhibit</clueType> NF-kappa B activation in response to these stimuli.</clue>
</event>
<event KT="Fact" id="E20">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T17"/>
<clue>Various antioxidants <clueType>inhibit</clueType> NF-kappa B activation in response to these stimuli.</clue>
</event>
<sentence id="S5">In this study, we have investigated the effects of <term id="T20" lex="selenium" sem="Organic_compound_other">selenium</term>, an integral component of <term id="T21" lex="glutathione_peroxidase" sem="Protein_molecule">glutathione peroxidase</term> (<term id="T22" lex="GPX" sem="Protein_molecule">GPX</term>), on <term id="T23" lex="NF-kappa_B_activation" sem="Other"><term id="T24" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<clue>In this study, we have investigated the effects of selenium, an integral component of glutathione peroxidase (GPX), on NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event KT="Investigation" id="E22" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E21"/>
<cause idref="T20"/>
<clue>In this study, we have <clueKT>investigated</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> selenium, an integral component of glutathione peroxidase (GPX), <linkTheme>on</linkTheme> NF-kappa B activation.</clue>
</event>
<sentence id="S6">In <term id="T25" lex="selenium-deprived_Jurkat" sem="Cell_cultured"><term id="T26" lex="selenium" sem="Organic_compound_other">selenium</term>-deprived Jurkat</term> and <term id="T27" lex="ESb-L_T_lymphocyte" sem="Cell_cultured">ESb-L T lymphocytes</term>, supplementation of <term id="T28" lex="selenium" sem="Organic_compound_other">selenium</term> led to a substantial increase of <term id="T29" lex="GPX_activity" sem="Other"><term id="T30" lex="GPX" sem="Protein_molecule">GPX</term> activity</term>.</sentence>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T28"/>
<clue><clueLoc>In selenium-deprived Jurkat</clueLoc> and ESb-L <clueLoc>T lymphocytes</clueLoc>, supplementation of selenium <clueType>led to</clueType> a substantial <clueType>increase</clueType> <linkTheme>of</linkTheme> GPX activity.</clue>
</event>
<event id="E123">
<type class="Negative_regulation"/>
<theme idref="T26"/>
<clue>In selenium-<clueType>deprived</clueType> <clueLoc>Jurkat</clueLoc> and ESb-L <clueLoc>T lymphocytes</clueLoc>, supplementation of selenium led to a substantial increase of GPX activity.</clue>
</event>
<event id="E223">
<type class="Negative_regulation"/>
<theme idref="T26"/>
<clue>In selenium-<clueType>deprived</clueType> Jurkat and <clueLoc>ESb-L T lymphocytes</clueLoc>, supplementation of selenium led to a substantial increase of GPX activity.</clue>
</event>
<sentence id="S7">Analysis of DNA binding revealed that <term id="T31" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation in response to <term id="T32" lex="TNF" sem="Protein_family_or_group">TNF</term> was significantly inhibited under these conditions.</sentence>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T32"/>
<clue>Analysis of DNA binding revealed that NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> TNF was significantly inhibited under these conditions.</clue>
</event>
<event KT="Analysis" Manner="High" id="E25">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E23"/>
<clue>Analysis of DNA binding <clueKT>revealed</clueKT> that NF-kappa B activation in response to TNF was <clueManner>significantly</clueManner> <clueType>inhibited</clueType> <linkCause>under</linkCause> <corefCause>these conditions</corefCause>.</clue>
</event>
<sentence id="S8">Likewise, reporter gene assays using luciferase constructs driven by the <term id="T33" lex="HIV-1_long_terminal_repeat" sem="DNA_domain_or_region"><term id="T34" lex="HIV-1" sem="Virus">HIV-1</term> long terminal repeat</term> showed a dose-dependent inhibition of <term id="T35" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> controlled <term id="T36" lex="gene_expression" sem="Other">gene expression</term> by <term id="T37" lex="selenium" sem="Organic_compound_other">selenium</term>.</sentence>
<event KT="Other" id="E26">
<type class="Regulation"/>
<theme idref="T36"/>
<cause idref="T35"/>
<clue>Likewise, reporter gene assays using luciferase constructs driven by the HIV-1 long terminal repeat showed a dose-dependent inhibition of NF-kappa B <clueType>controlled</clueType> gene expression by selenium.</clue>
</event>
<event KT="Analysis" id="E27">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T37"/>
<clue>Likewise, <clueExperiment>reporter gene assays using luciferase constructs driven by the HIV-1 long terminal repeat</clueExperiment> <clueKT>showed</clueKT> a dose-dependent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B controlled gene expression <linkCause>by</linkCause> selenium.</clue>
</event>
<sentence id="S9">The effects of <term id="T38" lex="selenium" sem="Organic_compound_other">selenium</term> were specific for <term id="T39" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>, since the activity of the transcription factor <term id="T40" lex="AP-1" sem="Protein_molecule">AP-1</term> was not suppressed.</sentence>
<event id="E28">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T38"/>
<clue>The <clueType>effects</clueType> <linkCause>of</linkCause> selenium were specific <linkTheme>for</linkTheme> NF-kappa B, since the activity of the transcription factor AP-1 was not suppressed.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Negative_regulation"/>
<theme idref="T40"/>
<cause idref="T38"/>
<clue>The effects of selenium were specific for NF-kappa B, since the activity of the transcription factor AP-1 was <cluePolarity>not</cluePolarity> <clueType>suppressed</clueType>.</clue>
<comment>No corefCause</comment></event>
<sentence id="S10">These data suggest that <term id="T41" lex="selenium_supplementation" sem="Other"><term id="T42" lex="selenium" sem="Organic_compound_other">selenium</term> supplementation</term> may be used to modulate the expression of <term id="T43" lex="NF-kappa_B_target_gene" sem="DNA_family_or_group"><term id="T44" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> target genes</term> and <term id="T45" lex="HIV-1" sem="Virus">HIV-1</term>.</sentence>
<event KT="Other" id="E30">
<type class="Gene_expression"/>
<theme idref="T43"/>
<clue>These data suggest that selenium supplementation may be used to modulate the <clueType>expression</clueType> <linkTheme>of</linkTheme> NF-kappa B target genes and HIV-1.</clue>
</event>
<event KT="Other" id="E31">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>These data suggest that selenium supplementation may be used to modulate the <clueType>expression</clueType> <linkTheme>of</linkTheme> NF-kappa B target genes and HIV-1.</clue>
</event>
<event CL="L1" KT="Analysis" id="E32" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E30"/>
<cause idref="T42"/>
<clue>These data <clueKT>suggest</clueKT> that selenium supplementation <clueCL>may</clueCL> be used to <clueType>modulate</clueType> the expression of NF-kappa B target genes and HIV-1.</clue>
</event>
<event CL="L1" KT="Analysis" id="E33" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E31"/>
<cause idref="T42"/>
<clue>These data <clueKT>suggest</clueKT> that selenium supplementation <clueCL>may</clueCL> be used to <clueType>modulate</clueType> the expression of NF-kappa B target genes and HIV-1.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
